The old beats the new – direct oral anticoagulants in severe antiphospholipid syndrome?

References

• 1 Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306. First citation in articleCrossref Medline, Google Scholar

• 2 Reiffel JA. Time in the Therapeutic Range for Patients Taking Warfarin in Clinical Trials. Circulation. 2017;135:1475–1477. First citation in articleCrossref Medline, Google Scholar

• 3 Pengo V, Denas G, Zoppellaro G, et al. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood. 2018;132:1365–71. First citation in articleCrossref Medline, Google Scholar

• 4 Laureano M, Crowther MA. Higher-risk APS: do we dare to DOAC? Blood. 2018;132:1357–8. First citation in articleCrossref Medline, Google Scholar